A Plus Biotechnology Co., Ltd. is a medical technology company focused on the research, development, manufacture, and sale of orthopedic medical equipment. Headquartered in New Taipei, Taiwan and founded in 2009, the company specializes in products designed for trauma care and orthopedic applications, such as internal fixation bone plates, bone nails, cables, spinal fixation systems, and custom surgical guide plates. Its offerings extend to solutions supporting bone healing, precise correction, and spinal support, addressing both acute injuries and chronic orthopedic conditions. The company also provides specialized devices for bone replacement, cartilage repair, and cell therapy. Serving hospitals and healthcare providers, its products are distributed domestically and exported to regions including mainland China, Asia, the United States, and Africa. Within the financial market, A Plus Biotechnology Co., Ltd. represents the intersection of advanced medical technology and growing healthcare demand, playing a vital role in the supply chain for surgical and trauma care equipment, and contributing to the progress of health technology in Asia and beyond.
Markedsdata leveret af TwelveData og Morningstar